These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

107 related articles for article (PubMed ID: 22891867)

  • 21. Mechanism of action of (-)-epigallocatechin-3-gallate: auto-oxidation-dependent inactivation of epidermal growth factor receptor and direct effects on growth inhibition in human esophageal cancer KYSE 150 cells.
    Hou Z; Sang S; You H; Lee MJ; Hong J; Chin KV; Yang CS
    Cancer Res; 2005 Sep; 65(17):8049-56. PubMed ID: 16140980
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Inhibition of melanoma growth and metastasis by combination with (-)-epigallocatechin-3-gallate and dacarbazine in mice.
    Liu JD; Chen SH; Lin CL; Tsai SH; Liang YC
    J Cell Biochem; 2001; 83(4):631-42. PubMed ID: 11746506
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigallocatechin gallate-loaded polysaccharide nanoparticles for prostate cancer chemoprevention.
    Rocha S; Generalov R; Pereira Mdo C; Peres I; Juzenas P; Coelho MA
    Nanomedicine (Lond); 2011 Jan; 6(1):79-87. PubMed ID: 21182420
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Tumor-Homing Cell-Penetrating Peptide Linked to Colloidal Mesoporous Silica Encapsulated (-)-Epigallocatechin-3-gallate as Drug Delivery System for Breast Cancer Therapy in Vivo.
    Ding J; Yao J; Xue J; Li R; Bao B; Jiang L; Zhu JJ; He Z
    ACS Appl Mater Interfaces; 2015 Aug; 7(32):18145-55. PubMed ID: 26225796
    [TBL] [Abstract][Full Text] [Related]  

  • 25. (-)-Epigallocatechin gallate (EGCG)-nanoethosomes as a transdermal delivery system for docetaxel to treat implanted human melanoma cell tumors in mice.
    Liao B; Ying H; Yu C; Fan Z; Zhang W; Shi J; Ying H; Ravichandran N; Xu Y; Yin J; Jiang Y; Du Q
    Int J Pharm; 2016 Oct; 512(1):22-31. PubMed ID: 27544847
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Excellent anti-proliferative and pro-apoptotic effects of (-)-epigallocatechin-3-gallate encapsulated in chitosan nanoparticles on human melanoma cell growth both in vitro and in vivo.
    Siddiqui IA; Bharali DJ; Nihal M; Adhami VM; Khan N; Chamcheu JC; Khan MI; Shabana S; Mousa SA; Mukhtar H
    Nanomedicine; 2014 Nov; 10(8):1619-26. PubMed ID: 24965756
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Phase I pharmacokinetic study of tea polyphenols following single-dose administration of epigallocatechin gallate and polyphenon E.
    Chow HH; Cai Y; Alberts DS; Hakim I; Dorr R; Shahi F; Crowell JA; Yang CS; Hara Y
    Cancer Epidemiol Biomarkers Prev; 2001 Jan; 10(1):53-8. PubMed ID: 11205489
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of bladder tumor growth by the green tea derivative epigallocatechin-3-gallate.
    Kemberling JK; Hampton JA; Keck RW; Gomez MA; Selman SH
    J Urol; 2003 Sep; 170(3):773-6. PubMed ID: 12913695
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Green Tea Catechin Is an Alternative Immune Checkpoint Inhibitor that Inhibits PD-L1 Expression and Lung Tumor Growth.
    Rawangkan A; Wongsirisin P; Namiki K; Iida K; Kobayashi Y; Shimizu Y; Fujiki H; Suganuma M
    Molecules; 2018 Aug; 23(8):. PubMed ID: 30126206
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Identification of epigallocatechin-3-gallate in green tea polyphenols as a potent inducer of p53-dependent apoptosis in the human lung cancer cell line A549.
    Yamauchi R; Sasaki K; Yoshida K
    Toxicol In Vitro; 2009 Aug; 23(5):834-9. PubMed ID: 19406223
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The specific anti-cancer activity of green tea (-)-epigallocatechin-3-gallate (EGCG).
    Wang YC; Bachrach U
    Amino Acids; 2002; 22(2):131-43. PubMed ID: 12395181
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The effect of green tea extract and EGCG on the signaling network in squamous cell carcinoma.
    Liu X; Zhang DY; Zhang W; Zhao X; Yuan C; Ye F
    Nutr Cancer; 2011; 63(3):466-75. PubMed ID: 21391127
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Oral administration of naturally occurring chitosan-based nanoformulated green tea polyphenol EGCG effectively inhibits prostate cancer cell growth in a xenograft model.
    Khan N; Bharali DJ; Adhami VM; Siddiqui IA; Cui H; Shabana SM; Mousa SA; Mukhtar H
    Carcinogenesis; 2014 Feb; 35(2):415-23. PubMed ID: 24072771
    [TBL] [Abstract][Full Text] [Related]  

  • 34. High doses of (-)-epigallocatechin-3-gallate from green tea induces cardiac fibrosis in mice.
    Cai Y; He SQ; Hong HQ; Cai YP; Zhao L; Zhang M
    Biotechnol Lett; 2015 Dec; 37(12):2371-7. PubMed ID: 26272391
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antitumor effect of green tea polyphenol epigallocatechin-3-gallate in ovarian carcinoma cells: evidence for the endothelin-1 as a potential target.
    Spinella F; Rosanò L; Decandia S; Di Castro V; Albini A; Elia G; Natali PG; Bagnato A
    Exp Biol Med (Maywood); 2006 Jun; 231(6):1123-7. PubMed ID: 16741061
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Transdermal delivery of (-)-epigallocatechin-3-gallate, a green tea polyphenol, in mice.
    Lambert JD; Kim DH; Zheng R; Yang CS
    J Pharm Pharmacol; 2006 May; 58(5):599-604. PubMed ID: 16640828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Epigallocatechin-3-gallate induces cell apoptosis of human chondrosarcoma cells through apoptosis signal-regulating kinase 1 pathway.
    Yang WH; Fong YC; Lee CY; Jin TR; Tzen JT; Li TM; Tang CH
    J Cell Biochem; 2011 Jun; 112(6):1601-11. PubMed ID: 21328612
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of (-)-epigallocatechin gallate, the main constituent of green tea, on lung metastasis with mouse B16 melanoma cell lines.
    Taniguchi S; Fujiki H; Kobayashi H; Go H; Miyado K; Sadano H; Shimokawa R
    Cancer Lett; 1992 Jul; 65(1):51-4. PubMed ID: 1511409
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Epigallocatechin gallate sensitizes CAL-27 human oral squamous cell carcinoma cells to the anti-metastatic effects of gefitinib (Iressa) via synergistic suppression of epidermal growth factor receptor and matrix metalloproteinase-2.
    Chang CM; Chang PY; Tu MG; Lu CC; Kuo SC; Amagaya S; Lee CY; Jao HY; Chen MY; Yang JS
    Oncol Rep; 2012 Nov; 28(5):1799-807. PubMed ID: 22923287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Green tea polyphenol (-)-epigallocatechin gallate suppressed the differentiation of murine osteoblastic MC3T3-E1 cells.
    Kamon M; Zhao R; Sakamoto K
    Cell Biol Int; 2009 Dec; 34(1):109-16. PubMed ID: 19947947
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.